vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and SPS COMMERCE INC (SPSC). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $192.7M, roughly 1.4× SPS COMMERCE INC). SPS COMMERCE INC runs the higher net margin — 13.4% vs 0.7%, a 12.7% gap on every dollar of revenue. On growth, SPS COMMERCE INC posted the faster year-over-year revenue change (12.7% vs -16.5%). SPS COMMERCE INC produced more free cash flow last quarter ($38.2M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

HCM vs SPSC — Head-to-Head

Bigger by revenue
HCM
HCM
1.4× larger
HCM
$270.8M
$192.7M
SPSC
Growing faster (revenue YoY)
SPSC
SPSC
+29.3% gap
SPSC
12.7%
-16.5%
HCM
Higher net margin
SPSC
SPSC
12.7% more per $
SPSC
13.4%
0.7%
HCM
More free cash flow
SPSC
SPSC
$34.9M more FCF
SPSC
$38.2M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
SPSC
SPSC
Revenue
$270.8M
$192.7M
Net Profit
$2.0M
$25.8M
Gross Margin
37.7%
70.4%
Operating Margin
-13.2%
18.0%
Net Margin
0.7%
13.4%
Revenue YoY
-16.5%
12.7%
Net Profit YoY
-83.6%
47.2%
EPS (diluted)
$0.00
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
SPSC
SPSC
Q4 25
$270.8M
$192.7M
Q3 25
$189.9M
Q2 25
$277.7M
$187.4M
Q1 25
$324.5M
$181.5M
Q4 24
$170.9M
Q3 24
$163.7M
Q2 24
$305.7M
$153.6M
Q1 24
$149.6M
Net Profit
HCM
HCM
SPSC
SPSC
Q4 25
$2.0M
$25.8M
Q3 25
$25.6M
Q2 25
$455.0M
$19.7M
Q1 25
$11.9M
$22.2M
Q4 24
$17.6M
Q3 24
$23.5M
Q2 24
$25.8M
$18.0M
Q1 24
$18.0M
Gross Margin
HCM
HCM
SPSC
SPSC
Q4 25
37.7%
70.4%
Q3 25
69.5%
Q2 25
0.1%
68.1%
Q1 25
48.0%
68.7%
Q4 24
67.5%
Q3 24
68.5%
Q2 24
41.1%
66.1%
Q1 24
65.6%
Operating Margin
HCM
HCM
SPSC
SPSC
Q4 25
-13.2%
18.0%
Q3 25
16.4%
Q2 25
-1.3%
14.1%
Q1 25
-5.0%
14.3%
Q4 24
14.5%
Q3 24
15.6%
Q2 24
-9.0%
15.1%
Q1 24
10.3%
Net Margin
HCM
HCM
SPSC
SPSC
Q4 25
0.7%
13.4%
Q3 25
13.5%
Q2 25
163.8%
10.5%
Q1 25
3.7%
12.2%
Q4 24
10.3%
Q3 24
14.3%
Q2 24
8.4%
11.7%
Q1 24
12.0%
EPS (diluted)
HCM
HCM
SPSC
SPSC
Q4 25
$0.00
$0.69
Q3 25
$0.67
Q2 25
$0.52
$0.52
Q1 25
$0.01
$0.58
Q4 24
$0.46
Q3 24
$0.62
Q2 24
$0.03
$0.48
Q1 24
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
SPSC
SPSC
Cash + ST InvestmentsLiquidity on hand
$1.4B
$151.4M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$973.9M
Total Assets
$1.8B
$1.2B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
SPSC
SPSC
Q4 25
$1.4B
$151.4M
Q3 25
$133.7M
Q2 25
$1.4B
$107.6M
Q1 25
$836.1M
$94.9M
Q4 24
$241.0M
Q3 24
$205.8M
Q2 24
$802.5M
$271.8M
Q1 24
$290.8M
Total Debt
HCM
HCM
SPSC
SPSC
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
SPSC
SPSC
Q4 25
$1.2B
$973.9M
Q3 25
$958.9M
Q2 25
$1.2B
$949.8M
Q1 25
$759.9M
$920.9M
Q4 24
$854.7M
Q3 24
$829.4M
Q2 24
$740.1M
$703.4M
Q1 24
$683.0M
Total Assets
HCM
HCM
SPSC
SPSC
Q4 25
$1.8B
$1.2B
Q3 25
$1.2B
Q2 25
$1.8B
$1.1B
Q1 25
$1.3B
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.3B
$854.5M
Q1 24
$839.8M
Debt / Equity
HCM
HCM
SPSC
SPSC
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
SPSC
SPSC
Operating Cash FlowLast quarter
$8.2M
$45.9M
Free Cash FlowOCF − Capex
$3.4M
$38.2M
FCF MarginFCF / Revenue
1.2%
19.8%
Capex IntensityCapex / Revenue
1.8%
4.0%
Cash ConversionOCF / Net Profit
4.21×
1.78×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$152.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
SPSC
SPSC
Q4 25
$8.2M
$45.9M
Q3 25
$60.6M
Q2 25
$-72.9M
$32.3M
Q1 25
$40.3M
$40.0M
Q4 24
$40.6M
Q3 24
$53.3M
Q2 24
$-39.8M
$29.4M
Q1 24
$34.1M
Free Cash Flow
HCM
HCM
SPSC
SPSC
Q4 25
$3.4M
$38.2M
Q3 25
$54.6M
Q2 25
$-82.2M
$25.7M
Q1 25
$32.5M
$33.8M
Q4 24
$34.3M
Q3 24
$48.1M
Q2 24
$-49.9M
$24.4M
Q1 24
$30.5M
FCF Margin
HCM
HCM
SPSC
SPSC
Q4 25
1.2%
19.8%
Q3 25
28.7%
Q2 25
-29.6%
13.7%
Q1 25
10.0%
18.6%
Q4 24
20.1%
Q3 24
29.4%
Q2 24
-16.3%
15.9%
Q1 24
20.4%
Capex Intensity
HCM
HCM
SPSC
SPSC
Q4 25
1.8%
4.0%
Q3 25
3.2%
Q2 25
3.3%
3.6%
Q1 25
2.4%
3.4%
Q4 24
3.6%
Q3 24
3.2%
Q2 24
3.3%
3.3%
Q1 24
2.4%
Cash Conversion
HCM
HCM
SPSC
SPSC
Q4 25
4.21×
1.78×
Q3 25
2.37×
Q2 25
-0.16×
1.64×
Q1 25
3.38×
1.80×
Q4 24
2.31×
Q3 24
2.27×
Q2 24
-1.54×
1.63×
Q1 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

SPSC
SPSC

Recurring Revenues$184.5M96%
One Time Revenues$8.1M4%
Set Up Fees$4.1M2%

Related Comparisons